What We Do
Explore the breadth of our portfolio across Therapeutic Areas and Partnered Programs.
Who We Are
Passionate individuals bring our ideas to life and help to solve the toughest challenges.
Culture & Careers
Passionate individuals bring our ideas to life and help to solve the toughest challenges.
Hematology and Oncology
Learn more about our work in Hematology and Oncology.
Inflammation and Autoimmunity
Learn more about our work in Inflammation and Autoimmunity, including Dermatology.
What We Do
Explore the breadth of our portfolio across Therapeutic Areas and Partnered Programs.
Who We Are
Passionate individuals bring our ideas to life and help to solve the toughest challenges.
Culture & Careers
Passionate individuals bring our ideas to life and help to solve the toughest challenges.
Hematology and Oncology
Learn more about our work in Hematology and Oncology.
Inflammation and Autoimmunity
Learn more about our work in Inflammation and Autoimmunity, including Dermatology.
What We Do
Explore the breadth of our portfolio across Therapeutic Areas and Partnered Programs.
Who We Are
Passionate individuals bring our ideas to life and help to solve the toughest challenges.
Culture & Careers
Passionate individuals bring our ideas to life and help to solve the toughest challenges.
Hematology and Oncology
Learn more about our work in Hematology and Oncology.
Inflammation and Autoimmunity
Learn more about our work in Inflammation and Autoimmunity, including Dermatology.
The Incyte Journey
Incyte is a global biopharmaceutical company on a mission to Solve On. With three core franchises in Hematology, Oncology and Inflammation and Autoimmunity, we are committed to developing and delivering innovative medicines for the patients.
Solve On. Stories
Discover the purpose that drives our mission—from our employee culture to the patients that inspire our innovative pipeline. Read the stories behind our innovative science, the communities we serve and the people who make it all possible.
Investment in Strong Science and R&D Excellence
Latest Press Release
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
Portfolio
We have a breadth of clinical programs within our portfolio across Hematology, Oncology, Dermatology, Other Therapeutic Areas, and Partnered Programs.